CLINICAL EFFICIENCY OF COMBINED AMINO-ACID COMPLEX USAGE IN COMPLEX TREATMENT OF PATIENTS WITH DIABETIC PERIPHERAL POLYNEYROPATHY
DOI:
https://doi.org/10.11603/2415-8798.2017.3.8082Keywords:
diabetic polyneuropathy, neuropathic pain, Keltican.Abstract
Standard treatment of diabetic polyneuropathy, one of the most common diabetes mellitus complications, is effective, but only leads to a temporary clinical effect.
The aim of the study – to increase the efficacy of treatment of neuropathic pain by incorporating Keltican drug into a complex therapy of diabetic polyneuropathy.
Results and Discussion. 64 patients with type 2 diabetes, complicated by diabetic polyneuropathy were examined. Patients were compared into two groups: the control group consisted of 32 patients, who received standard treatment, 32 patients of another group received additionally Keltican (1 capsule three times a day for a month). The assessment and intensity of neuropathic pain was performed using a modified questionnaire DN 4. Positive clinical effect of treatment was observed in both groups after 12-day treatment, and was maintained for a month. But such effect was preserved after 3 and 6 months only in the group with Keltican appointment.
Conclusions. Using the DN 4 questionnaire with a modified scale for evaluating the parameters of neuropathic pain can optimize the diagnosis of this complication in patients with diabetes mellitus. The inclusion of the Keltican in the standard complex therapy of diabetic polyneuropathy increases the clinical efficacy of neuropathic pain treatment and contributes to the preservation of the therapeutic effect for 6 months in 64.2 % of patients.
References
Bregovskiy, V.B. (2008). Bolevyye formy diabeticheskoy polineyropatii nizhnikh konechnostey: sovremennyye predstavleniya i vozmozhnosti lecheniya (obzor literatury) [Pain forms of diabetic polyneuropathy of the lower limbs: modern views and treatment options (literature review)]. Bol – Pain, 1, (18), 29-34 [in Russian].
Danilov, A.B. (2006). Farmakoterapiya bolevogo sindroma pri diabeticheskoy polinevropatii [Pharmacotherapy of pain syndrome in diabetic polyneuropathy]. Consiliummedicum – Consiliummedicum, 9, 123-126 [in Russian].
Danilov, A.B. & Davydov, O.S. (2007). Neyropaticheskaya bol [Neuropathic pain]. TS M : Borges, 198 [in Russian].
Kotov, S.V., Kalinin, A.P. & Rudakova, I.G. (2011). Diabeticheskaya neyropatiya [Diabetic neuropathy]. 2nd ed. rev. M. : OOO "Publishing house" Medical information agency ", 440 [in Russian].
Kravchun, N.A. (2007). Optimizatsiya medikamentoznogo lecheniya diabeticheskoy neyropatii: vse neobkhodimoye dostupno [Optimization of drug treatment for diabetic neuropathy: everything you need is available.]. Zdorovye Ukrainy – Health of Ukraine, 15, 65 [in Russian].
Levin, O.S. (2007). Lecheniye bolevogo sindroma pri polineyropatiyakh. Trudn patsiyent [Treatment of pain syndrome with polyneuropathies. Difficult patient] , 4, 27-32 [in Russian].
Mukhina, N.A., Moiseyeva, V.S. & Martynova, A.I. (2006). Vnutrenniye bolezni: uchebnik v 2 t. [Internal diseases: a textbook in 2 vol.]. M. : GEOTAR-Media, 98-145 [in Russian].
Nakaz MOZ Ukrayiny vid 21.12.2012 №1118 «Pro zatverdzhennia medyko-tekhnolohichnykh dokumentiv zi standartyzatsiieiu medychnoi dopomohy pry tsukrovomu diabeti 2 typu» nakaz MOZ Ukrayiny [The order of the Ministry of Health of Ukraine dated 21.12.2012 No 1118 "About the solidification of medical and technological documents in the standardization of medical care for diabetes type 2" MOZ Ukraine order]. Access mode: //www/moz.qov.ua/ua/portal/ dn_20121221_1118.html
Povoroznyuk V.V., Shynkarenko, T.Ye. & Pryymych, U.I. (2014). Neyropatychnyi komponent boliu pry zakhvoriuvanniakh kistkovo-miazovoi systemy: ohliad literatury ta rezultaty vlasnykh doslidzhen [Neuropathic component of pain in diseases of the bone and muscle system: a review of literature and the results of their own research]. Chastyna I. Bol. Sustavy. Pozvonochnyk – Part I. Pain. Joints Spinal column, 4, (16), 5-13 [in Ukrainian].
Bouhassira, D. Attal, N. & Alchaar, H. (2005). Comparison of pain syndromes associated with nervous or somatic lesions and development of a new neuropathic pain diagnostic questionnaire (DN4). Pain, (114), 29-36.
Bouhassira, D., Attal, N. & Fermanian, J. (2004). Development and validation of the Neuropathic Pain Symtom Inventory. Pain, (108).
Davis, M. (2006). The prevalence, severity and impact of painful diabetic peripheral neuropathy in type 2 diabetes. Diabetes Care, (29), 1518-1522.
Mibielli, M.A., Nunes, C.P. & Cohen, J.C. (2010). Treatment of Acute, Non-traumatic Pain Using a Combination of Diclofenaccholestyramine, Uridine Triphosphate, Cytidine Monophosphate, and Hydroxycobalamin. Proc. West. Pharmacol. Soc., (53), 5-12.
Muller, D. (2011). Lecheniшe nevropaticheskikh bolevykh sindromov. Rezul'taty otkrytogo issledovaniya preparata na osnove pirimidinovykh nukleotidov [Treatment of neuropathic pain syndromes. Results of an open study of a drug based on pyrimidine nucleotides]. Mezhdunarodnyy nevrologicheskiy zhurnal – International Neurological Journal, 1, (39), 48-50.
Downloads
Published
How to Cite
Issue
Section
License
Authors who sent their manuscript to "Вісник наукових досліджень. Bulletin of Scientific Research" Surgery agree to the following terms:
a. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
b. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
c. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access)